Loading...
Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder
Objectives: Describe the safety and tolerability of lisdexamfetamine dimesylate (LDX) and provide data on clinical effects for efficacy-related endpoints and pharmacokinetics in preschool-aged children with attention-deficit/hyperactivity disorder (ADHD). Methods: This phase 2, multicenter, open-lab...
Na minha lista:
| Udgivet i: | J Child Adolesc Psychopharmacol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Mary Ann Liebert, Inc., publishers
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7153646/ https://ncbi.nlm.nih.gov/pubmed/32233956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cap.2019.0117 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|